{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:51:07Z","timestamp":1790743867899,"version":"4.1.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T00:00:00Z","timestamp":1625270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T00:00:00Z","timestamp":1625270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s11926-021-01023-9","type":"journal-article","created":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T15:03:20Z","timestamp":1625324600000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":128,"title":["COVID-19 and Myositis: What We Know So Far"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7882-063X","authenticated-orcid":false,"given":"Ahmad","family":"Saud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2014-3925","authenticated-orcid":false,"given":"R","family":"Naveen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7531-8038","authenticated-orcid":false,"given":"Rohit","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2753-2990","authenticated-orcid":false,"given":"Latika","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,3]]},"reference":[{"issue":"8","key":"1023_CR1","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/s41584-020-0448-7","volume":"16","author":"C Galeotti","year":"2020","unstructured":"Galeotti C, Bayry J. Autoimmune and inflammatory diseases following COVID-19. Nat Rev Rheumatol. 2020 Aug;16(8):413\u20134.","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"1023_CR2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41584-020-00562-2","volume":"17","author":"KL Hyrich","year":"2021","unstructured":"Hyrich KL, Machado PM. Rheumatic disease and COVID-19: epidemiology and outcomes. Nat Rev Rheumatol. 2021 Feb;17(2):71\u20132.","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"1023_CR3","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s00296-020-04737-8","volume":"41","author":"R Naveen","year":"2021","unstructured":"Naveen R, Sundaram TG, Agarwal V, Gupta L. Teleconsultation experience with the idiopathic inflammatory myopathies: a prospective observational cohort study during the COVID-19 pandemic. Rheumatol Int. 2021;41(1):67\u201376. In a cohort of IIM, one-thirds resorted to voice-based teleconsultation services on an emergency basis. Over a quarter reported relapse, these being eight times more common in JDM than adult IIM.","journal-title":"Rheumatol Int"},{"key":"1023_CR4","doi-asserted-by":"crossref","unstructured":"Gupta L, Misra DP, Agarwal V, Balan S, Agarwal V. Response to: \u2018Telerheumatology in COVID-19 era: a study from a psoriatic arthritis cohort\u2019 by Costa et al. Ann Rheum Dis. 2020:annrheumdis-2020-217953. Patients with IIM were underrepresented among teleconsultations but overrepresented among hospital admissions in the pandemic period, suggesting the need for a tele-triage protocol based on the type of rheumatic disease.","DOI":"10.1136\/annrheumdis-2020-217953"},{"issue":"570","key":"1023_CR5","doi-asserted-by":"publisher","first-page":"eabd3876","DOI":"10.1126\/scitranslmed.abd3876","volume":"12","author":"Y Zuo","year":"2020","unstructured":"Zuo Y, Estes SK, Ali RA, Gandhi AA, Yalavarthi S, Shi H, et al. Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19. Sci Transl Med. 2020;12(570):eabd3876.","journal-title":"Sci Transl Med"},{"issue":"11","key":"1023_CR6","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1007\/s10072-020-04708-8","volume":"41","author":"VK Paliwal","year":"2020","unstructured":"Paliwal VK, Garg RK, Gupta A, Tejan N. Neuromuscular presentations in patients with COVID-19. Neurol Sci. 2020;41(11):3039\u201356.","journal-title":"Neurol Sci"},{"issue":"10223","key":"1023_CR7","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China The Lancet. 2020;395(10223):497\u2013506.","journal-title":"China The Lancet"},{"issue":"7","key":"1023_CR8","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1001\/jamacardio.2020.1286","volume":"5","author":"M Madjid","year":"2020","unstructured":"Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential effects of coronaviruses on the cardiovascular system: a review. JAMA Cardiol. 2020;5(7):831\u201340.","journal-title":"JAMA Cardiol"},{"issue":"17","key":"1023_CR9","doi-asserted-by":"publisher","first-page":"3621","DOI":"10.12998\/wjcc.v8.i17.3621","volume":"8","author":"R Talotta","year":"2020","unstructured":"Talotta R, Robertson E. Autoimmunity as the comet tail of COVID-19 pandemic. World J Clin Cases. 2020;8(17):3621\u201344.","journal-title":"World J Clin Cases"},{"issue":"7","key":"1023_CR10","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.3201\/eid2607.200445","volume":"26","author":"M Jin","year":"2020","unstructured":"Jin M, Tong Q. Rhabdomyolysis as potential late complication associated with COVID-19. Emerg Infect Dis. 2020;26(7):1618\u201320.","journal-title":"Emerg Infect Dis"},{"key":"1023_CR11","doi-asserted-by":"crossref","unstructured":"Suwanwongse K, Shabarek N. Rhabdomyolysis as a presentation of 2019 novel coronavirus disease. Cureus [Internet]. 2020 Apr 6 [cited 2021 Feb 10]. Available from: https:\/\/www.cureus.com\/articles\/30228-rhabdomyolysis-as-a-presentation-of-2019-novel-coronavirus-disease","DOI":"10.7759\/cureus.7561"},{"issue":"9","key":"1023_CR12","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1016\/j.radcr.2020.07.003","volume":"15","author":"R Husain","year":"2020","unstructured":"Husain R, Corcuera-Solano I, Dayan E, Jacobi AH, Huang M. Rhabdomyolysis as a manifestation of a severe case of COVID-19: a case report. Radiol Case Rep. 2020;15(9):1633\u20137.","journal-title":"Radiol Case Rep"},{"key":"1023_CR13","doi-asserted-by":"crossref","unstructured":"Singh B, Kaur P, Mechineni A, Maroules M. Rhabdomyolysis in COVID-19: report of four cases. Cureus [Internet]. 2020 27 [cited 2021 Feb 10]; Available from: https:\/\/www.cureus.com\/articles\/41837-rhabdomyolysis-in-covid-19-report-of-four-cases","DOI":"10.7759\/cureus.10686"},{"issue":"9","key":"1023_CR14","doi-asserted-by":"publisher","first-page":"e237616","DOI":"10.1136\/bcr-2020-237616","volume":"13","author":"K Taxbro","year":"2020","unstructured":"Taxbro K, Kahlow H, Wulcan H, Fornarve A. Rhabdomyolysis and acute kidney injury in severe COVID-19 infection. BMJ Case Rep. 2020 Sep;13(9):e237616.","journal-title":"BMJ Case Rep"},{"key":"1023_CR15","doi-asserted-by":"crossref","unstructured":"Beydon M, Chevalier K, Al Tabaa O, Hamroun S, Delettre A-S, Thomas M, et al. Myositis as a manifestation of SARS-CoV-2. Ann Rheum Dis. 2020; annrheumdis-2020-217573.","DOI":"10.1136\/annrheumdis-2020-217573"},{"key":"1023_CR16","doi-asserted-by":"crossref","unstructured":"Zhang H, Charmchi Z, Seidman RJ, Anziska Y, Velayudhan V, Perk J. COVID-19\u2013associated myositis with severe proximal and bulbar weakness. Muscle Nerve [Internet]. 2020 Sep [cited 2021 Feb 10];62(3). Available from: https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1002\/mus.27003","DOI":"10.1002\/mus.27003"},{"key":"1023_CR17","unstructured":"Gokhale Y, Patankar A, Holla U, Shilke M, Kalekar L, Karnik ND, et al. Dermatomyositis during COVID-19 pandemic (a case series): is there a cause effect relationship? J Assoc Physicians India. 2020;68(11). This series describes four new cases of typical dermatomyositis where the onset of the illness was preceded by COVID-19 infection, raising the possibility of a direct pathogenic link."},{"issue":"10","key":"1023_CR18","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.3174\/ajnr.A6711","volume":"41","author":"WA Mehan","year":"2020","unstructured":"Mehan WA, Yoon BC, Lang M, Li MD, Rincon S, Buch K. Paraspinal myositis in patients with COVID-19 infection. Am J Neuroradiol. 2020;41(10):1949\u201352. The importance of this article is for its reporting of para-spinal myositis cases which helps describe this rare complication not commonly reported in the literature following COVID-19 infection as well as re-emphasizing the extent and pervasiveness of the myositis associated with this disease.","journal-title":"Am J Neuroradiol"},{"issue":"11","key":"1023_CR19","doi-asserted-by":"publisher","first-page":"3195","DOI":"10.1007\/s10067-020-05334-7","volume":"39","author":"C Ferri","year":"2020","unstructured":"Ferri C, Giuggioli D, Raimondo V, L\u2019Andolina M, Tavoni A, Cecchetti R, et al. COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series. Clin Rheumatol. 2020 Nov;39(11):3195\u2013204.","journal-title":"Clin Rheumatol"},{"key":"1023_CR20","doi-asserted-by":"crossref","unstructured":"Sriwastava S, Tandon M, Kataria S, Daimee M, Sultan S. New onset of ocular myasthenia gravis in a patient with COVID-19: a novel case report and literature review. J Neurol [Internet]. 2020 Oct 12 [cited 2021 Feb 10]; Available from: http:\/\/link.springer.com\/10.1007\/s00415-020-10263-1","DOI":"10.1007\/s00415-020-10263-1"},{"key":"1023_CR21","doi-asserted-by":"crossref","unstructured":"Assini A, Gandoglia I, Damato V, Rikani K, Evoli A, Del Sette M. Myasthenia gravis associated with anti-MuSK antibodies developed after SARS-CoV-2 infection. Eur J Neurol. 2021; ene.14721.","DOI":"10.1111\/ene.14721"},{"issue":"18","key":"1023_CR22","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"W Guan","year":"2020","unstructured":"Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708\u201320.","journal-title":"N Engl J Med"},{"issue":"8","key":"1023_CR23","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1093\/rheumatology\/keaa351","volume":"59","author":"S Rivas-Garc\u00eda","year":"2020","unstructured":"Rivas-Garc\u00eda S, Bernal J, Bachiller-Corral J. Rhabdomyolysis as the main manifestation of coronavirus disease 2019. Rheumatology. 2020;59(8):2174\u20136.","journal-title":"Rheumatology."},{"issue":"10229","key":"1023_CR24","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054\u201362.","journal-title":"Lancet"},{"key":"1023_CR25","doi-asserted-by":"crossref","unstructured":"Bahouth S, Chuang K, Olson L, Rosenthal D. COVID-19 related muscle denervation atrophy. Skeletal Radiol [Internet]. 2021 Jan 31 [cited 2021 Feb 10]; Available from: http:\/\/link.springer.com\/10.1007\/s00256-021-03721-y","DOI":"10.1007\/s00256-021-03721-y"},{"issue":"4","key":"1023_CR26","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.jvscit.2020.08.021","volume":"6","author":"M Almadani","year":"2020","unstructured":"Almadani M, Shiferson A, Swearingen B, Shih M, Jacob T, Rhee R. Compartment syndrome secondary to viral myositis as initial presentation in COVID-19 patient. J Vasc Surg Cases Innov Tech. 2020 Dec;6(4):524\u20137.","journal-title":"J Vasc Surg Cases Innov Tech"},{"key":"1023_CR27","doi-asserted-by":"crossref","unstructured":"Kumar NB. Does COVID-19-related cachexia mimic cancer-related cachexia? Examining mechanisms, clinical biomarkers, and potential targets for clinical management. J Cachexia Sarcopenia Muscle. 2021; jcsm.12681.","DOI":"10.1002\/jcsm.12681"},{"issue":"6","key":"1023_CR28","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1001\/jama.2020.12603","volume":"324","author":"A Carf\u00ec","year":"2020","unstructured":"Carf\u00ec A, Bernabei R, Landi F, for the Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603.","journal-title":"JAMA."},{"issue":"8","key":"1023_CR29","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1002\/art.22751","volume":"56","author":"LJ Vegosen","year":"2007","unstructured":"Vegosen LJ, Weinberg CR, O\u2019Hanlon TP, Targoff IN, Miller FW, Rider LG. Seasonal birth patterns in myositis subgroups suggest an etiologic role of early environmental exposures. Arthritis Rheum. 2007;56(8):2719\u201328.","journal-title":"Arthritis Rheum"},{"key":"1023_CR30","doi-asserted-by":"crossref","unstructured":"Bolig TC, Abdulaziz N, Schiopu E. Complete recovery from COVID-19 bilateral pneumonia in an immunosuppressed man with immune-mediated necrotizing myopathy. Schiavon F, editor. Case Rep Rheumatol. 2020 Oct 21;2020:1\u20135.","DOI":"10.1155\/2020\/8886324"},{"issue":"4","key":"1023_CR31","doi-asserted-by":"publisher","first-page":"A734","DOI":"10.1016\/j.chest.2020.08.688","volume":"158","author":"E Fares","year":"2020","unstructured":"Fares E, Tayyar R, Pathak K, Damiano C, Kuntz C. Myasthenia gravis crisis triggered by COVID-19. Chest. 2020 Oct;158(4):A734.","journal-title":"Chest."},{"key":"1023_CR32","first-page":"1","volume":"2020","author":"E Aksoy","year":"2020","unstructured":"Aksoy E, Oztutgan T. COVID-19 presentation in association with myasthenia gravis: a case report and review of the literature. Case Rep Infect Dis. 2020;2020:1\u20134.","journal-title":"Case Rep Infect Dis"},{"issue":"12","key":"1023_CR33","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/S1474-4422(20)30413-0","volume":"19","author":"S Muppidi","year":"2020","unstructured":"Muppidi S, Guptill JT, Jacob S, Li Y, Farrugia ME, Guidon AC, et al. COVID-19-associated risks and effects in myasthenia gravis (CARE-MG). Lancet Neurol. 2020 Dec;19(12):970\u20131.","journal-title":"Lancet Neurol"},{"key":"1023_CR34","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.3389\/fneur.2020.01053","volume":"11","author":"AE Camelo-Filho","year":"2020","unstructured":"Camelo-Filho AE, Silva AMS, Estephan EP, Zambon AA, Mendon\u00e7a RH, Souza PVS, et al. Myasthenia gravis and COVID-19: clinical characteristics and outcomes. Front Neurol. 2020;11:1053.","journal-title":"Front Neurol"},{"issue":"3","key":"1023_CR35","doi-asserted-by":"publisher","first-page":"2001618","DOI":"10.1183\/13993003.01618-2020","volume":"56","author":"M Giannini","year":"2020","unstructured":"Giannini M, Ohana M, Nespola B, Zanframundo G, Geny B, Meyer A. Similarities between COVID-19 and anti-MDA5 syndrome: what can we learn for better care? Eur Respir J. 2020;56(3):2001618. This study draws striking parallels between anti-MDA5 syndrome (an autoimmune disease) and COVID-19 which both present with remarkably similar presentations suggesting that future studies should further examine whether there are similar pathological autoimmune mechanisms or pathways involved in both diseases. The potential role of corticosteroids in treating COVID-19 is discussed as corticosteroids have shown benefit in anti-MDA5 syndrome.","journal-title":"Eur Respir J"},{"issue":"11","key":"1023_CR36","doi-asserted-by":"publisher","first-page":"102666","DOI":"10.1016\/j.autrev.2020.102666","volume":"19","author":"E De Lorenzis","year":"2020","unstructured":"De Lorenzis E, Natalello G, Gigante L, Verardi L, Bosello SL, Gremese E. What can we learn from rapidly progressive interstitial lung disease related to anti-MDA5 dermatomyositis in the management of COVID-19? Autoimmun Rev. 2020 Nov;19(11):102666.","journal-title":"Autoimmun Rev"},{"key":"1023_CR37","first-page":"43","volume":"1","author":"AG Morris","year":"1988","unstructured":"Morris AG. Interferons. Immunol Suppl. 1988;1:43\u20135.","journal-title":"Immunol Suppl"},{"issue":"7","key":"1023_CR38","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1002\/art.24621","volume":"60","author":"S Sato","year":"2009","unstructured":"Sato S, Hoshino K, Satoh T, Fujita T, Kawakami Y, Fujita T, et al. RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung disease. Arthritis Rheum. 2009 Jul;60(7):2193\u2013200.","journal-title":"Arthritis Rheum"},{"key":"1023_CR39","doi-asserted-by":"crossref","unstructured":"Alunno A, Najm A, Machado PM, Bertheussen H, Burmester GR, Carubbi F, et al. EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19. Ann Rheum Dis. 2021; annrheumdis-2020-219724.","DOI":"10.1136\/annrheumdis-2020-219724"},{"key":"1023_CR40","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.3389\/fphar.2020.01333","volume":"11","author":"TS Schoot","year":"2020","unstructured":"Schoot TS, Kerckhoffs APM, Hilbrands LB, van Marum RJ. Immunosuppressive drugs and COVID-19: a review. Front Pharmacol. 2020;11:1333.","journal-title":"Front Pharmacol"},{"key":"1023_CR41","doi-asserted-by":"publisher","first-page":"198163","DOI":"10.1016\/j.virusres.2020.198163","volume":"289","author":"A Elhabyan","year":"2020","unstructured":"Elhabyan A, Elyaacoub S, Sanad E, Abukhadra A, Elhabyan A, Dinu V. The role of host genetics in susceptibility to severe viral infections in humans and insights into host genetics of severe COVID-19: A systematic review. Virus Res. 2020;289:198163.","journal-title":"Virus Res"},{"issue":"1","key":"1023_CR42","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s41927-020-00165-0","volume":"4","author":"J Ciaffi","year":"2020","unstructured":"Ciaffi J, Meliconi R, Ruscitti P, Berardicurti O, Giacomelli R, Ursini F. Rheumatic manifestations of COVID-19: a systematic review and meta-analysis. BMC Rheumatol. 2020;4(1):65.","journal-title":"BMC Rheumatol"},{"issue":"5","key":"1023_CR43","doi-asserted-by":"publisher","first-page":"e781","DOI":"10.1212\/NXI.0000000000000781","volume":"7","author":"MC Dalakas","year":"2020","unstructured":"Dalakas MC. Guillain-Barr\u00e9 syndrome: The first documented COVID-19\u2013triggered autoimmune neurologic disease: more to come with myositis in the offing. Neurol - Neuroimmunol Neuroinflammation. 2020 Sep;7(5):e781.","journal-title":"Neurol - Neuroimmunol Neuroinflammation"},{"key":"1023_CR44","doi-asserted-by":"crossref","unstructured":"Aboudounya MM, Heads RJ. COVID-19 and Toll-like receptor 4 (TLR4): SARS-CoV-2 may bind and activate TLR4 to increase ACE2 expression, facilitating entry and causing hyperinflammation. In: Dozio E, editor. Mediators Inflamm. 2021 Jan 14;2021:1\u201318.","DOI":"10.1155\/2021\/8874339"},{"issue":"10","key":"1023_CR45","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1136\/annrheumdis-2020-217522","volume":"79","author":"S Megremis","year":"2020","unstructured":"Megremis S, Walker TDJ, He X, Ollier WER, Chinoy H, Hampson L, et al. Antibodies against immunogenic epitopes with high sequence identity to SARS-CoV-2 in patients with autoimmune dermatomyositis. Ann Rheum Dis. 2020;79(10):1383\u20136. This study found immunogenic epitopes in patients with dermatomyositis that resemble epitopes from SARS-CoV-2. These epitopes are believed to activate CD8 T cells and should guide further studies looking at inflammatory mechanisms in COVID-19-induced myositis.","journal-title":"Ann Rheum Dis"},{"key":"1023_CR46","doi-asserted-by":"publisher","first-page":"155404","DOI":"10.1016\/j.cyto.2020.155404","volume":"138","author":"P Thepmankorn","year":"2021","unstructured":"Thepmankorn P, Bach J, Lasfar A, Zhao X, Souayah S, Chong ZZ, et al. Cytokine storm induced by SARS-CoV-2 infection: the spectrum of its neurological manifestations. Cytokine. 2021 Feb;138:155404.","journal-title":"Cytokine."},{"key":"1023_CR47","doi-asserted-by":"crossref","unstructured":"Zhang Q, Shan KS, Minalyan A, O\u2019Sullivan C, Nace T. A rare presentation of Coronavirus Disease 2019 (COVID-19) induced viral myositis with subsequent rhabdomyolysis. Cureus [Internet]. 2020 May 12 [cited 2021 Feb 10]; Available from: https:\/\/www.cureus.com\/articles\/31422-a-rare-presentation-of-coronavirus-disease-2019-covid-19-induced-viral-myositis-with-subsequent-rhabdomyolysis","DOI":"10.7759\/cureus.8074"},{"issue":"9","key":"1023_CR48","first-page":"819","volume":"137","author":"CD Naylor","year":"1987","unstructured":"Naylor CD, Jevnikar AM, Witt NJ. Sporadic viral myositis in two adults. CMAJ Can Med Assoc J J Assoc Medicale Can. 1987 Nov 1;137(9):819\u201321.","journal-title":"CMAJ Can Med Assoc J J Assoc Medicale Can"},{"key":"1023_CR49","doi-asserted-by":"crossref","unstructured":"Gupta L, Gupta P. Telecommunication in the Covid19 era: as an assessment tool for patient with dermatomyositis. Indian J Rheum 2021. [in press]. 2021.","DOI":"10.4103\/injr.injr_286_20"},{"key":"1023_CR50","doi-asserted-by":"crossref","unstructured":"Gupta L, Misra DP, Agarwal V, et al. Management of rheumatic diseases in the time of covid-19 pandemic: perspectives of rheumatology practitioners from India. Ann Rheum Dis 2020. doi:10.1136\/annrheumdis-2020-217509. [Epub ahead of print: 16 Apr 2020].","DOI":"10.1136\/annrheumdis-2020-217509"},{"issue":"2","key":"1023_CR51","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1093\/rheumatology\/keaa610","volume":"60","author":"L Gupta","year":"2021","unstructured":"Gupta L, Lilleker JB, Agarwal V, Chinoy H, Aggarwal R. COVID-19 and myositis \u2013 unique challenges for patients. Rheumatology. 2021;60(2):907\u201310. COVID-19 has incurred a detrimental effect on patients with myositis, with widespread difficulties in procuring medicines, delayed biologic infusions, and disrupted physiotherapy sessions. Such delays and omissions in clinical care may translate to poorer outcomes in the future.","journal-title":"Rheumatology."},{"issue":"3","key":"1023_CR52","doi-asserted-by":"publisher","first-page":"134","DOI":"10.5114\/reum.2020.96665","volume":"58","author":"A Opinc","year":"2020","unstructured":"Opinc A, \u0141ukasik Z, Makowska J. The attitude of Polish rheumatology patients towards telemedicine in the age of the COVID-19 pandemic. Reumatologia\/Rheumatology. 2020;58(3):134\u201341.","journal-title":"Reumatologia\/Rheumatology."},{"issue":"5","key":"1023_CR53","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1210\/clinem\/dgaa148","volume":"105","author":"UB Kaiser","year":"2020","unstructured":"Kaiser UB, Mirmira RG, Stewart PM. Our response to COVID-19 as endocrinologists and diabetologists. J Clin Endocrinol Metab. 2020;105(5):1299\u2013301.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10270","key":"1023_CR54","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/S0140-6736(20)32656-8","volume":"397","author":"C Huang","year":"2021","unstructured":"Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021 Jan;397(10270):220\u201332.","journal-title":"Lancet"},{"issue":"18","key":"1023_CR55","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1056\/NEJMp2003539","volume":"382","author":"JE Hollander","year":"2020","unstructured":"Hollander JE, Carr BG. Virtually perfect? Telemedicine for Covid-19. N Engl J Med. 2020;382(18):1679\u201381.","journal-title":"N Engl J Med"},{"key":"1023_CR56","unstructured":"Kocoloski A, Ward C, Koontz D, Oddis C, Aggarwal R. Functional measures and patient home self-assessments in the idiopathic inflammatory myopathies [abstract]. Arthritis Rheumatol [Internet]. 2017 [cited 2021 Feb 13];69 (supp 10). Available from: https:\/\/acrabstracts.org\/abstract\/functional-measures-and-patient-home-self-assessments-in-the-idiopathic-inflammatory-myopathies\/"},{"key":"1023_CR57","unstructured":"Oldroyd A, Yimer B, Little M, Dixon W, Chinoy H. Daily myositis symptom changes collected via a smartphone-based app are associated with flare occurrence \u2013 providing evidence of potential digital biomarkers [abstract]. Arthritis Rheumatol [Internet]. 2020 [cited 2021 Feb 14];72 (supp 10). Available from: https:\/\/acrabstracts.org\/abstract\/daily-myositis-symptom-changes-collected-via-a-smartphone-based-app-are-associated-with-flare-occurrence-providing-evidence-of-potential-digital-biomarkers\/."},{"key":"1023_CR58","doi-asserted-by":"crossref","unstructured":"Ahmed S, Gupta L. Perception about social media use by rheumatology journals: survey among the attendees of IRACON 2019. Indian J Rheumatol 2020;0(0):0.","DOI":"10.4103\/injr.injr_15_20"},{"issue":"3","key":"1023_CR59","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1097\/01.rct.0000250115.10457.e9","volume":"31","author":"C-H Lu","year":"2007","unstructured":"Lu C-H, Tsang Y-M, Yu C-W, Wu M-Z, Hsu C-Y, Shih TT-F. Rhabdomyolysis: magnetic resonance imaging and computed tomography findings. J Comput Assist Tomogr. 2007 Jun;31(3):368\u201374.","journal-title":"J Comput Assist Tomogr"},{"issue":"1","key":"1023_CR60","doi-asserted-by":"publisher","first-page":"165","DOI":"10.2214\/ajr.174.1.1740165","volume":"174","author":"LO Delaney-Sathy","year":"2000","unstructured":"Delaney-Sathy LO, Fessell DP, Jacobson JA, Hayes CW. Sonography of diabetic muscle infarction with MR imaging, CT, and pathologic correlation. Am J Roentgenol. 2000 Jan;174(1):165\u20139.","journal-title":"Am J Roentgenol"},{"issue":"9","key":"1023_CR61","first-page":"272","volume":"67","author":"FY Khan","year":"2009","unstructured":"Khan FY. Rhabdomyolysis: a review of the literature. Neth J Med. 2009 Oct;67(9):272\u201383.","journal-title":"Neth J Med"},{"issue":"3","key":"1023_CR62","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1128\/CMR.00001-08","volume":"21","author":"NF Crum-Cianflone","year":"2008","unstructured":"Crum-Cianflone NF. Bacterial, fungal, parasitic, and viral myositis. Clin Microbiol Rev. 2008 Jul;21(3):473\u201394.","journal-title":"Clin Microbiol Rev"},{"issue":"5","key":"1023_CR63","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1002\/mus.26679","volume":"60","author":"E Pancheri","year":"2019","unstructured":"Pancheri E, Lanzafame M, Zam\u00f2 A, Angheben A, Sartoris S, Zorzi A, et al. Benign acute viral myositis in African migrants: a clinical, serological, and pathological study. Muscle Nerve. 2019 Nov;60(5):586\u201390.","journal-title":"Muscle Nerve"},{"issue":"4","key":"1023_CR64","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s11926-018-0732-6","volume":"20","author":"I Pinal-Fernandez","year":"2018","unstructured":"Pinal-Fernandez I, Casal-Dominguez M, Mammen AL. Immune-mediated necrotizing myopathy. Curr Rheumatol Rep. 2018 Apr;20(4):21.","journal-title":"Curr Rheumatol Rep"},{"issue":"4","key":"1023_CR65","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/j.1399-3062.2009.00407.x","volume":"11","author":"ML Ritter","year":"2009","unstructured":"Ritter ML, Pirofski L. Mycophenolate mofetil: effects on cellular immune subsets, infectious complications, and antimicrobial activity. Transpl Infect Dis Off J Transplant Soc. 2009 Aug;11(4):290\u20137.","journal-title":"Transpl Infect Dis Off J Transplant Soc"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-021-01023-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11926-021-01023-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-021-01023-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T15:28:43Z","timestamp":1626276523000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11926-021-01023-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,3]]},"references-count":65,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["1023"],"URL":"https:\/\/doi.org\/10.1007\/s11926-021-01023-9","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,3]]},"assertion":[{"value":"22 May 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights Informed Consent"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"63"}}